Literature DB >> 24135278

Cancer-associated osteoclast differentiation takes a good look in the miR(NA)ror.

David L Waning1, Khalid S Mohammad, Theresa A Guise.   

Abstract

Tumor-bone cell interactions are critical for the development of metastasis-related osteolytic bone destruction. In this issue of Cancer Cell, Ell and colleagues show how a discrete miRNA network regulates osteoclastogenesis during breast cancer bone metastasis. A signature of upregulated miRNAs may have diagnostic and therapeutic implications for bone metastases.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24135278      PMCID： PMC3897244          DOI： 10.1016/j.ccr.2013.10.001

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  11 in total

1.  Intercellular adhesion molecule 1 discriminates functionally different populations of human osteoblasts: characteristic involvement of cell cycle regulators.

Authors:  Y Tanaka; A Maruo; K Fujii; M Nomi; T Nakamura; S Eto; Y Minami
Journal:  J Bone Miner Res       Date:  2000-10       Impact factor: 6.741

Review 2.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

3.  Interferon-β-induced miR-155 inhibits osteoclast differentiation by targeting SOCS1 and MITF.

Authors:  Jun Zhang; Hongying Zhao; Jinping Chen; Bing Xia; Yongming Jin; Wei Wei; Jianjian Shen; Yazeng Huang
Journal:  FEBS Lett       Date:  2012-07-04       Impact factor: 4.124

Review 4.  Cancer to bone: a fatal attraction.

Authors:  Katherine N Weilbaecher; Theresa A Guise; Laurie K McCauley
Journal:  Nat Rev Cancer       Date:  2011-05-19       Impact factor: 60.716

5.  MicroRNA-223 is a key factor in osteoclast differentiation.

Authors:  T Sugatani; K A Hruska
Journal:  J Cell Biochem       Date:  2007-07-01       Impact factor: 4.429

6.  TGF-β upregulates miR-181a expression to promote breast cancer metastasis.

Authors:  Molly A Taylor; Khalid Sossey-Alaoui; Cheryl L Thompson; David Danielpour; William P Schiemann
Journal:  J Clin Invest       Date:  2012-12-17       Impact factor: 14.808

7.  Signaling between transforming growth factor β (TGF-β) and transcription factor SNAI2 represses expression of microRNA miR-203 to promote epithelial-mesenchymal transition and tumor metastasis.

Authors:  Xiangming Ding; Serk In Park; Laurie K McCauley; Cun-Yu Wang
Journal:  J Biol Chem       Date:  2013-02-27       Impact factor: 5.157

8.  Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis.

Authors:  Brian Ell; Laura Mercatali; Toni Ibrahim; Neil Campbell; Heidi Schwarzenbach; Klaus Pantel; Dino Amadori; Yibin Kang
Journal:  Cancer Cell       Date:  2013-10-14       Impact factor: 31.743

Review 9.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

10.  Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption.

Authors:  Fumitaka Mizoguchi; Yayoi Izu; Tadayoshi Hayata; Hiroaki Hemmi; Kazuhisa Nakashima; Takashi Nakamura; Shigeaki Kato; Nobuyuki Miyasaka; Yoichi Ezura; Masaki Noda
Journal:  J Cell Biochem       Date:  2010-04-01       Impact factor: 4.429
View more
  8 in total

Review 1.  Metastatic stem cells: sources, niches, and vital pathways.

Authors:  Thordur Oskarsson; Eduard Batlle; Joan Massagué
Journal:  Cell Stem Cell       Date:  2014-03-06       Impact factor: 24.633

Review 2.  Tumour-derived miRNAs and bone metastasis.

Authors:  Martine Croset; Casina Kan; Philippe Clézardin
Journal:  Bonekey Rep       Date:  2015-05-13

3.  MiR-1228 promotes breast cancer cell growth and metastasis through targeting SCAI protein.

Authors:  Luoqiang Lin; Dan Liu; Hongyan Liang; Li Xue; Changlei Su; Ming Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

4.  The role of microRNAs in bone metastasis.

Authors:  Eugenio Zoni; Gabri van der Pluijm
Journal:  J Bone Oncol       Date:  2016-07-08       Impact factor: 4.072

5.  Differential Co-expression and Regulatory Network Analysis Uncover the Relapse Factor and Mechanism of T Cell Acute Leukemia.

Authors:  Mei Luo; Qiong Zhang; Mengxuan Xia; Feifei Hu; Zhaowu Ma; Zehua Chen; An-Yuan Guo
Journal:  Mol Ther Nucleic Acids       Date:  2018-05-29       Impact factor: 8.886

6.  miR-135 regulated breast cancer proliferation and epithelial-mesenchymal transition acts by the Wnt/β-catenin signaling pathway.

Authors:  Daqiong Jiang; Bo Zhou; Yan Xiong; Hongbing Cai
Journal:  Int J Mol Med       Date:  2019-01-29       Impact factor: 4.101

7.  Two Distinct Subtypes Revealed in Blood Transcriptome of Breast Cancer Patients With an Unsupervised Analysis.

Authors:  Wenlong Ming; Hui Xie; Zixi Hu; Yuanyuan Chen; Yanhui Zhu; Yunfei Bai; Hongde Liu; Xiao Sun; Yun Liu; Wanjun Gu
Journal:  Front Oncol       Date:  2019-10-01       Impact factor: 6.244

Review 8.  MicroRNAs and Osteolytic Bone Metastasis: The Roles of MicroRNAs in Tumor-Induced Osteoclast Differentiation.

Authors:  Tadayoshi Kagiya
Journal:  J Clin Med       Date:  2015-08-28       Impact factor: 4.241
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.